Melanoma and microbiota: Current understanding and future directions
Bertrand Routy(Centre Hospitalier de l’Université de Montréal), Laurence Zitvogel(Institut Gustave Roussy), Geke A.P. Hospers(University Medical Center Groningen), Allyson L. Byrd(Immunité et Cancer), Laura Mählmann(Seerave Foundation), Morten L. Isaksen, Hassane M. Zarour(University of Pittsburgh), Ze’ev A. Ronai(Cedars-Sinai Medical Center), Diwakar Davar(University of Pittsburgh), Martin J. Blaser(Rutgers, The State University of New Jersey), Kasey L. Couts(University of Colorado Anschutz Medical Campus), Gregory D. Sepich‐Poore(Northwestern University), Kathy D. McCoy(University of Calgary), Sumanta K. Pal(City of Hope), Florent Malard(Sorbonne Université), Lisa Derosa(Institut Gustave Roussy), Marlies Meisel(UPMC Hillman Cancer Center), Rinse K. Weersma(University Medical Center Groningen), Randy F. Sweis(University of Illinois Chicago), Guido Kroemer(Institut Universitaire de France), Jennifer L. McQuade(The University of Texas MD Anderson Cancer Center), Katrine Whiteson(University of California, Irvine), Giorgio Trinchieri(National Cancer Institute), Tanisha Jackson(Melanoma Research Alliance), Fyza Y. Shaikh(Johns Hopkins University), Howard C. Hang(Scripps Institution of Oceanography), Liping Zhao(Lanzhou University), Nathalie Corvaı̈a(Erytech Pharma (France)), Marcel R.M. van den Brink(City Of Hope National Medical Center), Christina K. Baumgartner(AbbVie (United States)), Eran Segal(Weizmann Institute of Science)
Cited by 78
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Host microbiota constantly control maturation and function of microglia in the CNS
|Nature Neuroscience|2015|3.4k
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k